Stockreport

Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the appointment of David Nassif, J.D., as Chief Financial Officer, effe [Read more]